Transcripta Bio

Transcripta Bio

HealthPalo Alto, United States

Transcripta Bio is an AI-driven drug discovery startup focused on developing small molecule therapeutics to modulate gene expression disease signatures. The company aims to advance IND-enabling studies and clinical preparation for neurological diseases, including autism spectrum disorder and muscular dystrophy. Their innovative approach leverages robotic platforms and AI models to enhance drug discovery success rates.

$24MVisit website ↗

🏆 Featured in Datapile’s Q3 2026 USA Funding Report

Read the Q3 2026 USA report →
Add this badge to your site
Featured in Datapile’s Q3 2026 USA Funding Report
<a href="https://datapile.co/reports/q3-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 USA Funding Report</a>

Funding history

  1. $24M2026-07-23
    Source: news.google.com ↗

Founder

Chris Moxham
Chris Moxham
Founder & CEO

Investors in Transcripta Bio

Backers from this company's tracked funding rounds.

  • JAZZ Venture Partners
  • BlueYard Capital
  • Mayo Clinic
  • Omnimed

More Health companies

Recently funded startups in the same category.

Related on Datapile